Recently, the high-tech enterprise identification management network issued a notice to record and publicize the fourth batch of high-tech enterprises recognized by Jiangsu Province certification institutions in 2022, and the new research and development institution of our hospital, Nanjing Carbon Silicon Artificial Intelligence Biomedical Technology Research Institute, passed the identification of the fourth batch of high-tech enterprises in Jiangsu Province in 2022.
Nanjing Institute of Carbon Silicon Artificial Intelligence Biomedical Technology is a new R&D institution jointly
established by the talent team of Professor Yan Chao of Nanjing University, the main business direction is the
development and application of artificial intelligence multi-omics integrated analysis technology, artificial intelligence-assisted
RAS targeted drug development, the construction and application of organoid sample bank, etc., and has achieved remarkable
achievements in technology research and development, business incubation, talent introduction, industry-university-research
cooperation, and gathering innovative resources.
At present, the Institute of Artificial Intelligence Biomedical Technology of Nanjing University has incubated and introduced
a total of 12 enterprises, of which two have passed the identification of high-tech enterprises, with nearly 200 employees and
a cumulative introduction of social capital of more than 100 million.
In the future, the Institute will continue to introduce high-level innovative and entrepreneurial talents, provide all-round and
multi-level precision incubation services for talents and enterprises at different stages of development, and help start-ups grow
with high quality and high-level development; Increase investment in scientific research, accelerate the transformation of existing
scientific research achievements, and strive to become a high-end biomedical technology incubator in Jiangbei New Area.